Back to Journals » Infection and Drug Resistance » Volume 1

High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India

Authors Tiwari HK, Sapkota D, Sen MR

Published 30 November 2008 Volume 2008:1 Pages 57—61


Review by Single-blind

Peer reviewer comments 3

Hare Krishna Tiwari1, Darshan Sapkota2, Malaya Ranjan Sen1

1Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India; 2Department of Microbiology, Universal College of Medical Sciences, Bhairahawa, Nepal

Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) is an important nosocomial and community pathogen. The objectives of this study were to estimate the prevalence of multidrug-resistant MRSA strains in clinical specimens and to investigate the sensitivity pattern of these strains against various antibiotics used for treating hospitalized and out patients. Strains were identified using standard procedures, and their sensitivity pattern was investigated using such techniques as disc diffusion, minimum inhibitory concentration (MIC), and the mecA gene PCR. Among 783 isolates of S. aureus, 301 (38.44%) were methicillin-resistant, of which 217 (72.1%) were found to be multidrug-resistant. Almost all MRSA strains were resistant to penicillin, 95.68% were resistant to cotrimoxazole, 92.36% were resistant to chloramphenicol, 90.7% were resistant to norfloxacin, 76.1% were resistant to tetracycline, and 75.75% were resistant to ciprofloxacin. Vancomycin was the most effective drug, with only 0.33% of MRSA strains being resistant to it. It is concluded that antibiotics other than vancomycin can be used as anti-MRSA agents after a sensitivity test so as to preclude the emergence of resistance to it and that prevailing problems in chemotherapy will escalate unless indiscriminate and irrational usage of antibiotics is checked.

Keywords: multidrug-resistant MRSA, prevalence, India

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Improving tuberculosis diagnostics with biomarkers

Shu CC, Wang JY, Lee LN, Yu CJ, Luh KT

Current Biomarker Findings 2015, 5:13-19

Published Date: 7 May 2015

Determination of factors controlling the particle size and entrapment efficiency of noscapine in PEG/PLA nanoparticles using artificial neural networks

Shalaby KS, Soliman ME, Casettari L, Bonacucina G, Cespi M, Palmieri GF, Sammour OA, El Shamy AA

International Journal of Nanomedicine 2014, 9:4953-4964

Published Date: 23 October 2014

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?

Pergolizzi J, Alon E, Baron R, Bonezzi C, Dobrogowski J, Gálvez R, Jensen T, Kress H-G, Marcus MA, Morlion B, Perrot S, Treede R-D

Journal of Pain Research 2011, 4:203-210

Published Date: 21 July 2011

Profound thrombocytopenia after primary exposure to eptifibatide

Nicholas B Norgard, Brian T Badgley

Drug, Healthcare and Patient Safety 2010, 2:163-167

Published Date: 21 September 2010

Immunological and genetic aspects of asthma and allergy

Anne-Marie Madore, Catherine Laprise

Journal of Asthma and Allergy 2010, 3:107-121

Published Date: 20 August 2010

Exploration of a genomic expression and pathway analysis approach to neurocognitive performance: preliminary findings

Chad A Bousman, Gursharan Chana, Stephen J Glatt, et al

Neurobehavioral HIV Medicine 2010, 2:23-32

Published Date: 12 July 2010

Hemodialysis for hyperammonemia associated with ornithine transcarbamylase deficiency

Jacob F Collen, Nealanjon P Das, Jonathan M Koff, Robert T Neff, Kevin C Abbott

The Application of Clinical Genetics 2008, 1:1-5

Published Date: 24 July 2008